Biognosys: Biognosys AG: Biognosys Announces Commercial Availability of NULISA Proteomics Assay Services for Biomarker Research
Under a strategic partnership with Alamar Biosciences, Biognosys is a provider of choice of NULISA multiplex assay services for biopharma researchThe NULISAseq CNS Disease and Inflammation panels a...
Read full article »
Biognosys is a Switzerland-based SaaS platform that offers mass spectrometry-powered proteomics solutions for cell line engineering and protein quantification applications.
Read more